Articular cartilage injury often leads to vascular endothelial cell (VEC) infiltration, disrupting the microenvironment between cartilage and subchondral bone, thereby compromising cartilage repair quality. Curcumin (Cur) is a natural polyphenol with anti-inflammatory and anti-angiogenic properties that holds promise for therapeutic applications. However, its clinical utility is limited due to poor solubility and instability. To address these challenges, we developed a curcumin-loaded silk fibroin nanoparticle (Cur-SN) delivery system to inhibit VEC infiltration and promote cartilage regeneration. Cur-SNs were prepared and characterised to evaluate their physicochemical properties. The effects of Cur-SN on VEC apoptosis and senescence were assessed, and the underlying mechanism by which Cur-SN regulates mitochondrial homeostasis via the Drp1/ROS pathway was investigated. Additionally, a rat knee cartilage defect model was established, in which Cur-SN combined with a BMSC-loaded hydrogel was implanted. Cartilage differentiation and VEC infiltration levels in newly formed tissues were subsequently analysed. In vitro experiments demonstrated that Cur-SN upregulated Drp1 and ROS levels, leading to mitochondrial homeostasis disruption. This, in turn, induced VEC apoptosis and senescence while significantly inhibited VEC infiltration. Furthermore, Cur-SN effectively counteracted the inhibitory effects of VEC activation on BMSC chondrogenic differentiation. In vivo experiments revealed that Cur-SN reduced VEC infiltration and angiogenesis in newly formed tissues, thereby promoting hyaline cartilage regeneration at the defect site. Cur-SN enhances cartilage repair by upregulating Drp1 expression and ROS levels, thereby disrupting mitochondrial homeostasis, inducing VEC apoptosis and senescence, and inhibiting VEC infiltration.
Zhao et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: